Novo Nordisk shares take a hit after a report revealed Eli Lilly’s better weight loss drug
25,000 people begin taking Wegovy each week, but Novo Nordisk stock is sinking anyway
Weight-loss drug startup Metsera wants to take on Novo and Lilly. Here’s what you need to know
Why is Novo Nordisk’s stock up? Here’s what to know about its weight-loss drug Wegovy’s heart disease trials